This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Myhre, A. G. Articles by Husebye, E. S. Search for Related Content PubMed PubMed Citation Articles by Myhre, A. G. Articles by Husebye, E. S. Pubmed/NCBI databases Medline Plus Health Information Addison's Disease

Autoimmune Adrenocortical Failure in Norway Autoantibodies and Human Leukocyte Antigen Class II Associations Related to Clinical Features

Department of Pediatrics (A.G.M.), Akershus Central Hospital, N-1474 Nordbyhagen, Norway; Division of Endocrinology, Institute of Medicine (A.G.M, K.L., E.S.H.), Haukeland University Hospital, N-5021 Bergen, Norway; Institute of Immunology (D.E.U.), The National Hospital, N-0027 Oslo, Norway; Department of Medicine (S.U.), Rogaland Central Hospital, N-4003 Stavanger, Norway; Department of Medicine (B.G.N.), Haugesund Hospital, N-5500 Haugesund, Norway; Division of Endocrinology, Institute of Medicine (K.J.F.), University Hospital of Trondheim, N-7006 Trondheim, Norway; Department of Medicine (T.T.), University Hospital of Tromsø, N-9038 Tromsø, Norway; and Department of Medicine (J.I.S.), Stord Hospital, N-5400 Stord, Norway

Address all correspondence and requests for reprints to: Anne Grethe Myhre M.D., Department of Pediatrics, Akershus Central Hospital, N-1474 Nordbyhagen, Norway. E-mail: Anne.Myhre{at}med.uib.no

Abstract

Autoimmune destruction of the adrenal cortex is the most common cause of primary adrenocortical insufficiency (Addison’s disease) in industrialized countries. We have investigated a large Norwegian cohort of patients with Addison’s disease in terms of clinical manifestations, autoantibodies, and human leukocyte antigen (HLA) class II haplotypes. The study comprised 94 patients (54 females) of ages 6–85 yr (mean 45 yr) with, either isolated Addison’s disease or part of autoimmune polyendocrine syndrome type II. Among those diagnosed before the age of thirty, 53% were men, while among those diagnosed at 30 or above, 30% were men. Altogether 77 (82%) of the 94 patients had autoantibodies against 21-hydroxylase (21OH). Thirty-eight of the 40 patients with disease duration 5 yr or less had such autoantibodies. This frequency fell to 60% among patients with a disease duration greater than 35 yr. Five women had gonadal failure. This failure correlated with antibodies against side-chain cleavage enzyme (P = 0.03). Antibodies against glutamic acid decarboxylase and IA2 correlated with the presence of type 1 diabetes (P < 0.005 and P = 0.003, respectively). The frequency of the HLA DRB1*03-DQA1*05-DQB1*02 (DR3-DQ2) and DRB1*04-DQA1*03-DQB1*0302 (DR4-DQ8) haplotypes were positively correlated to Addison’s disease, whereas the DRB1*01-DQA1*0101-DQB1*0501 (DR1-DQ5) haplotype was negatively correlated. In addition, the DRB1*04 subtype DRB1*0404 was increased among Addison patients relative to controls.

We verify that autoimmunity is the main cause of Addison’s disease in our cohort. In younger patients, the disease is equally common in men and women. Measurement of autoantibodies against 21OH is a valuable tool in establishing the etiological diagnosis, especially in patients with a short disease duration. Addison’s disease is associated with the DR3-DQ2 and DR4 (0404)-DQ8 haplotypes. A particularly high risk for disease development is observed when these occur in a heterozygous combination (DR3-DQ2/DR4-DQ8).

This article has been cited by other articles:

				T. M. Triolo, E. E. Baschal, T. K. Armstrong, C. S. Toews, P. R. Fain, M. J. Rewers, L. Yu, D. Miao, G. S. Eisenbarth, P. A. Gottlieb, et al. Homozygosity of the Polymorphism MICA5.1 Identifies Extreme Risk of Progression to Overt Adrenal Insufficiency among 21-Hydroxylase Antibody-Positive Patients with Type 1 Diabetes J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4517 - 4523. [Abstract] [Full Text] [PDF]

				L. R. Mandel Endocrine and Autoimmune Aspects of the Health History of John F. Kennedy Ann Intern Med, September 1, 2009; 151(5): 350 - 354. [Abstract] [Full Text] [PDF]

				M. M Erichsen, K. Lovas, K. J Fougner, J. Svartberg, E. R Hauge, J. Bollerslev, J. P Berg, B. Mella, and E. S Husebye Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death Eur. J. Endocrinol., February 1, 2009; 160(2): 233 - 237. [Abstract] [Full Text] [PDF]

				B. Skinningsrud, E. S. Husebye, S. H. Pearce, D. O. McDonald, K. Brandal, A. B. Wolff, K. Lovas, T. Egeland, and D. E. Undlien Polymorphisms in CLEC16A and CIITA at 16p13 Are Associated with Primary Adrenal Insufficiency J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3310 - 3317. [Abstract] [Full Text] [PDF]

				Z Gombos, R Hermann, M Kiviniemi, S Nejentsev, K Reimand, V Fadeyev, P Peterson, R Uibo, and J Ilonen Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations Eur. J. Endocrinol., December 1, 2007; 157(6): 757 - 761. [Abstract] [Full Text] [PDF]

				P. Elfstrom, S. M. Montgomery, O. Kampe, A. Ekbom, and J. F. Ludvigsson Risk of Primary Adrenal Insufficiency in Patients with Celiac Disease J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3595 - 3598. [Abstract] [Full Text] [PDF]

				M. Rotondi, L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani Role of Chemokines in Endocrine Autoimmune Diseases Endocr. Rev., August 1, 2007; 28(5): 492 - 520. [Abstract] [Full Text] [PDF]

				R. Bergthorsdottir, M. Leonsson-Zachrisson, A. Oden, and G. Johannsson Premature Mortality in Patients with Addison's Disease: A Population-Based Study J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4849 - 4853. [Abstract] [Full Text] [PDF]

				E. S. Husebye, E. Bratland, G. Bredholt, M. Fridkin, M. Dayan, and E. Mozes The Substrate-Binding Domain of 21-Hydroxylase, the Main Autoantigen in Autoimmune Addison's Disease, Is an Immunodominant T Cell Epitope Endocrinology, May 1, 2006; 147(5): 2411 - 2416. [Abstract] [Full Text] [PDF]

				J. M. Barker Type 1 Diabetes-Associated Autoimmunity: Natural History, Genetic Associations, and Screening J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1210 - 1217. [Abstract] [Full Text] [PDF]

				C. Betterle, F. Lazzarotto, A. C. Spadaccino, D. Basso, M. Plebani, B. Pedini, S. Chiarelli, and M. Albergoni Celiac disease in North Italian patients with autoimmune Addison's disease Eur. J. Endocrinol., February 1, 2006; 154(2): 275 - 279. [Abstract] [Full Text] [PDF]

				J M Greer and M P Pender The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DR{beta}1 chain is associated with the clinical course of multiple sclerosis J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 656 - 662. [Abstract] [Full Text] [PDF]

				M. Rotondi, A. Falorni, A. De Bellis, S. Laureti, P. Ferruzzi, P. Romagnani, A. Buonamano, E. Lazzeri, C. Crescioli, M. Mannelli, et al. Elevated Serum Interferon-{gamma}-Inducible Chemokine-10/CXC Chemokine Ligand-10 in Autoimmune Primary Adrenal Insufficiency and in Vitro Expression in Human Adrenal Cells Primary Cultures after Stimulation with Proinflammatory Cytokines J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2357 - 2363. [Abstract] [Full Text] [PDF]

				G. Gambelunghe, I. Kockum, V. Bini, G. D. Giorgi, F. Celi, C. Betterle, R. Giordano, R. Libe, A. Falorni, and on behalf of the Umbria Type 1 Diabetes Registry a Retrovirus-Like Long-Terminal Repeat DQ-LTR13 and Genetic Susceptibility to Type 1 Diabetes and Autoimmune Addison's Disease Diabetes, March 1, 2005; 54(3): 900 - 905. [Abstract] [Full Text] [PDF]

				G. W. Wolkersdorfer, C. Marx, J. Brown, S. Schroder, M. Fussel, E. P. Rieber, E. Kuhlisch, G. Ehninger, and S. R. Bornstein Prevalence of HLA-DRB1 Genotype and Altered Fas/Fas Ligand Expression in Adrenocortical Carcinoma J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1768 - 1774. [Abstract] [Full Text] [PDF]

				J. M. Barker, A. Ide, C. Hostetler, L. Yu, D. Miao, P. R. Fain, G. S. Eisenbarth, and P. A. Gottlieb Endocrine and Immunogenetic Testing in Individuals with Type 1 Diabetes and 21-Hydroxylase Autoantibodies: Addison's Disease in a High-Risk Population J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 128 - 134. [Abstract] [Full Text] [PDF]

				A. Blomhoff, B. A. Lie, A. G. Myhre, E. H. Kemp, A. P. Weetman, H. E. Akselsen, E. S. Huseby, and D. E. Undlien Polymorphisms in the Cytotoxic T Lymphocyte Antigen-4 Gene Region Confer Susceptibility to Addison's Disease J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3474 - 3476. [Abstract] [Full Text] [PDF]

				G. S. Eisenbarth and P. A. Gottlieb Autoimmune Polyendocrine Syndromes N. Engl. J. Med., May 13, 2004; 350(20): 2068 - 2079. [Full Text] [PDF]